SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-077707
Filing Date
2022-07-06
Accepted
2022-07-06 16:18:17
Documents
1
Period of Report
2022-07-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2220515-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2220515-3_4seq1.xml 4 4034
  Complete submission text file 0001104659-22-077707.txt   5423
Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address
Dowden Nathan J (Reporting) CIK: 0001873392 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40969 | Film No.: 221068931